American Academy of PA (AAPA)

Search

Filter Content

The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.

Results 1 - 27 of 27

9368-bronchiectasis

Rapid Recap: Considering a Comprehensive Approach for Bronchiectasis Management

Advances in the Diagnosis, Assessment, and Therapeutic Management of BTC

9368-bronchiectasis

Considering a Comprehensive Approach for Bronchiectasis Management

Improving the Diagnosis and Management of PPF: Rapid Recap

Improving the Diagnosis and Management of PPF: A Focus on SSc-ILD and IPF

Negative and Cognitive Symptoms of CIAS: A Focus on Digital Therapeutics

9351ciastitleslide264x

A Continued Focus on Cognitive Impairment Associated With Schizophrenia (CIAS)

Addressing DMD Time to Diagnosis: Microlearning for Pediatricians & Primary Care

9345-t2d-2634x149

Breaking Barriers in Weight Management for Your Patients with T2D

Improving the Management of Patients with DMD: Emerging Evidence & Treatment Strategies

Understanding PNH and Other Complement-mediated Hematologic Disorders

Getting to Know PNH

Current and Emerging Treatment Options in PNH

9274-slide-download-263x149

Relapse, Progression, and Treatment of the Patient with MS - Slide Deck

Relapse, Progression, and Treatment of the Patient with MS

Understanding Myelofibrosis

Risk Stratification in Myelofibrosis Management

Current and Emerging JAK Inhibitors

9278-isth-explore

Risks and Benefits of Hemophilia Gene Therapy: An EXPLORE Learning Experience

9256-0002_Thumbnail

Conference Updates in DMD and LGMD (WMS and MDA)

A Changing Conversation: Delaying T1D Onset

9260-activity-image-263x149

Providing a Medical Home for Kids with Rare Lung Disease - Live Meeting Recording

GLP-1 RAs: Real-World Patient-Care Strategies for Type 2 Diabetes

The Role of Behavioral Medicine in Reducing Opiod Use

The Role of Behavioral Medicine in Reducing Opioid Use

9270-lgmd explore

Limb-Girdle Muscular Dystrophy EXPLORE Module

9262 ntm gr enduring

NTM-LD: Improving Diagnosis, Individualized Treatment, and Adherence

Cognitive Impairment Associated With Schizophrenia